Related Experiment Videos
Polymer-grafted starch microparticles for oral and nasal immunization
M R McDermott1, P L Heritage, V Bartzoka
1Department of Pathology, McMaster University, Hamilton, Ontario, Canada. mcdermot@fhs.mcmaster.ca
Immunology and Cell Biology
|July 31, 1998
Summary
A novel silicone-grafted starch microparticle system enhances oral and intranasal vaccine delivery. This system improves antigen immunogenicity and may aid in inducing oral tolerance, offering advantages for mucosal vaccine strategies.
Area of Science:
- Biomaterials Science
- Vaccinology
- Immunology
Background:
- Oral vaccine delivery systems are crucial for widespread immunization.
- Microparticle systems are explored for enhanced antigen delivery.
- Developing effective mucosal vaccine delivery remains a challenge.
Purpose of the Study:
- To develop and evaluate a novel silicone polymer-grafted starch microparticle system for vaccine delivery.
- To assess the efficacy of this system for oral and intranasal administration.
- To investigate the underlying mechanisms of antigen-microparticle interaction and immune response.
Main Methods:
- Fabrication of silicone polymer-grafted starch microparticles.
- In vitro assessment of antigen release and degradation.
- In vivo evaluation of mucosal immunogenicity following oral and intranasal administration.
- Analysis of antibody responses, including T-helper cell profiles.
Main Results:
- The novel microparticle system demonstrated efficacy for both oral and intranasal vaccine delivery.
- Unlike other systems, it did not retard antigen release or protect against degradation.
- A unique physiochemical interaction between antigen and silicone within the starch matrix was observed.
- This interaction enhanced mucosal immunogenicity, promoting a predominant Th2 antibody response.
Conclusions:
- The developed microparticle system is advantageous for delivering small antigen quantities, particularly via the intranasal route.
- The system's unique properties facilitate mucosal immunogenicity.
- This novel approach shows potential for inducing oral tolerance, a key goal in immunotherapy.